Extended panel of biomarkers for long term monitoring of effectiveness of 3 direct antiviral regimen in HCV genotype 1b infection: results from a Romanian infectious disease hospital

Extended panel of biomarkers for long term monitoring of effectiveness of 3 direct antiviral regimen in HCV genotype 1b infection: results from a Romanian infectious disease hospital

Background: Hepatitis C virus can be eradicated with antiviral therapy, thus reducing the risk of disease progression and death associated with the final stage of liver disease.

Bibliographic Details
Main Authors:	Harja-Alexa Ioana-Alina, Mihaela Luca Catalina, Manciuc Carmen Doina, Vata Andrei, Badescu Aida, Hurmuzache Mihnea-Eudoxiu, Ciocan Alexandra Mirela, Hunea Ioana Maria, Iancu Luminita-Smaranda
Format:	Article
Language:	English
Published:	Sciendo 2021-01-01
Series:	Romanian Journal of Laboratory Medicine
Subjects:	hepatitis c virus compensated cirrhosis direct-acting antiviral agents
Online Access:	https://doi.org/10.2478/rrlm-2020-0040

Similar Items

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
by: Dorota Zarębska-Michaluk, et al.
Published: (2021-07-01)

Antiviral therapy of HCV-cirrhosis: case of sequential treatment and review of literature
by: Kakharman Yesmembetov, et al.
Published: (2018-03-01)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals
by: Silvia Molina-Carrión, et al.
Published: (2020-07-01)

Antiviral therapy of HCV in the cirrhotic and transplant candidate
Published: (2006-04-01)

Treatment of HCV infection in patients with cirrhosis
by: Angelo Alves de Mattos, et al.
Published: (2010-01-01)

Antiviral therapy in HCV-infected decompensated cirrhotics
by: Danish Fazal, et al.
Published: (2010-01-01)

Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection
by: Pinchera B, et al.
Published: (2023-02-01)

High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world setting
by: Qunying Han, et al.
Published: (2019-06-01)

Liver Damage Associated with SARS-CoV-2 Infection—Myth or Reality?
by: Mihaela Cătălina Luca, et al.
Published: (2023-02-01)

HCV cure for everyone or which challenges remain?
by: Jürgen Kurt Rockstroh
Published: (2015-04-01)

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation
by: Cenderello G, et al.
Published: (2015-12-01)

ROMANIAN INVESTORS PORTFOLIO. ONLINE VERSUS ASSISTED TRADING
by: Ioana Ancuţa IANCU
Published: (2017-05-01)

Evaluation of handgrip strength as a predictor of sarcopenia in patients with HCV-related cirrhosis
by: Mohammed Magdy Salama, et al.
Published: (2023-05-01)

Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis
by: S N Batskikh, et al.
Published: (2018-11-01)

Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience
by: Eun Ju Cho, et al.
Published: (2012-06-01)

HEPATITA E – EFECTUL ASUPRA FICATULUI ŞI DINCOLO DE ACESTA
by: Mihaela Cătălina Luca, et al.
Published: (2018-12-01)

NON-INVASIVE TOOLS TO ASSESS THE RISK OF VARICES-NEEDING-TREATMENT IN CIRRHOSIS SECONDARY TO HCV
by: Laima Alam, et al.
Published: (2021-02-01)

Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis
by: Hafiza Arooba Riaz, et al.
Published: (2023-05-01)

Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study
by: Luca Rinaldi, et al.
Published: (2019-08-01)

PERSPECTIVES OF TREATMENT OF TERMINAL LIVER DISEASE IN CHRONIC HCV-INFECTION
by: E. N. German, et al.
Published: (2022-12-01)

WAITING DAAS LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTS
by: Giovanni Faria SILVA, et al.

Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs)
by: Waleed Attia Hassan, et al.
Published: (2023-10-01)

The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection
by: D. V. Garbuzenko
Published: (2021-11-01)

Serum MicroRNAs as Predictors for HCV Progression and Response to Treatment in Pakistani Patients
by: Sadia Manzoor, et al.
Published: (2023-02-01)

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman
by: Hamid Hasson, et al.
Published: (2014-12-01)

Treatment of Chronic HCV Infection in Special Populations
Published: (2006-04-01)

Online Communication And PR in Romanian Public Administration. The Case Study of Public Institutions From Transylvania
by: Delia Cristina BALABAN, et al.
Published: (2016-02-01)

Clinical and epidemiological profile of genotype 3 HCV patients in the South of Brazil
by: Marisa Boff Costa, et al.
Published: (2020-07-01)

Possible diagnostic role of microRNA-122 in chronic HCV infection and hepatocellular carcinoma
by: Asmaa Thabet, et al.
Published: (2023-05-01)

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
by: Shrikant Dasharath Warkad, et al.
Published: (2018-07-01)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.

Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis
by: JiHyun An, et al.
Published: (2022-09-01)

Effect of direct-acting antiviral drugs on portal circulation hemodynamics in cirrhotic patients infected with HCV
by: Alshymaa A. Hassnine, et al.
Published: (2022-02-01)

Diagnostic Value of Serum Markers of Liver Fibrosis in Patients with HCV-Infection
by: S.L. Melanich
Published: (2013-11-01)

Framing Gender in Romanian 2019’s Presidential Elections. A Comparison between Broadsheet and Tabloid Content Newspapers
by: Veronica Campian, et al.
Published: (2023-05-01)

Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment
by: Florin Mihai, et al.
Published: (2020-04-01)

Retail optimization in Romanian metallurgical industry by applying of fuzzy networks concept
by: Ioana Adrian, et al.
Published: (2017-01-01)

Strong correlation by ultrasonography of hepatomegaly and the presence of co-infection in HIV/HCV cirrhotic patients
by: Denise Cerqueira Paranaguá Vezozzo, et al.

The coagulation changes associated with acute variceal bleeding in patients with HCV-induced cirrhosis as assessed by rotational thromboelastometry
by: Mona A. Abu El-Makarem, et al.
Published: (2024-03-01)

Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals
by: Federica Vernuccio, et al.
Published: (2022-05-01)